Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Biswas, Partha Sundar"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Experiences from First 100 Cases of COVID Associated Rhino-orbito- Cerebral Mucormycosis Epidemic Treated from a Tertiary Care Centre in Eastern India : An Otorhinolaryngologist Prospective
    (THE INDIAN MEDICAL ASSOCIATION, 2024-05) Das, Sudip Kumar; Chatterjee, Pritam; Chakraborty, Aneek; Sengupta, Anindita; Barman, Debasish; Mukhopadhyay, Debasis; Srivastava, Smiti Rani; Adhikari, Souvik; Biswas, Partha Sundar; Basu, Keya
    Background : Early clinical presentations of Rhino-orbito-cerebral Mucormycosis (ROCM) are often underappreciated. Awareness and recognition of clinico-radiological features that may be more suggestive of mucormycosis can expedite management in this rapidly progressive disease. Materials and Methods : All patients of Rhino-orbito-cerebral Mucormycosis (ROCM) admitted to our facility from 24th May, 2021 to 24th August, 2021 are studied. Clinical, radiological and surgical findings are recorded and analysed. Observation and Results : Our experiences of dealing with first 100 cases presented in less than 3 months' time amidst COVID-19 pandemic with the hope of defining demography of population at risk, early diagnosis and recommendations for management of mucormycosis are summarised in details. Conclusion : Strong clinical suspicion is mainstay for early diagnosis. Anti-fungal medications are the mainstay of management along with surgical debridement. MRI is essential tool for diagnosis, evaluating progression and surgical planning. Regular endoscopic follow-ups are vital in detecting remnant and thus reducing recurrences.

IMSEAR is the collaborative product of Health Literature, Library and Information Services (HELLIS) Network Member Libraries in the WHO South-East Asia Region.
HELLIS is coordinated by WHO Regional Office for South-East Asia.

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback